Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Soliris ® (eculizumab)
has been granted orphan drug designation (ODD) by Japan’s Ministry of
Health, Labour and Welfare (MHLW) for the treatment of patients with
neuromyelitis optica (NMO), a life-threatening, ultra-rare neurologic
Behold, Portal Masters! Activision Publishing, Inc., a wholly owned
subsidiary of Activision Blizzard, Inc. (NASDAQ: ATVI) is pleased to
announce that Skylanders
Trap Team is officially available at major retailers
nationwide on Xbox 360 ™ and Xbox One ™
video game and entertainment systems from Microsoft, PlayStation ®
3 and PlayStation ® 4 computer entertainment systems,
Nintendo’s Wii ™ system, Nintendo’s Wii U ™ system,
and a completely unique adventure is also available on the Nintendo 3DS ™
Orville Redenbacher’s, a brand of ConAgra Foods, Inc. (NYSE:CAG), has
teamed with business mogul Bethenny Frankel and her popular line of
Skinnygirl products to introduce a satisfying new popcorn treat –
Skinnygirl Microwave Popcorn.
Silver Spring Networks, Inc. (NYSE:SSNI), a leading networking platform
and solutions provider for smart energy networks, today announced that
it will release its financial results for the third quarter ended
September 30, 2014 after the close of market on Wednesday, November 5,
Sign-up for SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Lannett Company, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of October 27, 2014 -- LCI investment picks
Binkow & Goldberg LLP , representing investors of Rayonier,
Inc. (“Rayonier” or the “Company”) (NYSE:RYN), has filed a class
action lawsuit in the United States District Court for the Middle
District of Florida on behalf of a class (the “Class”) comprising
purchasers of Rayonier securities between January 27, 2014 and November
7, 2014, inclusive (the “Class Period”).
Please contact Lesley
Portnoy or Casey
Sadler at (310) 201-9150, or at email@example.com
to discuss this matter.
Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Digital River, Inc.
(“Digital River” or the “Company”) (Nasdaq: DRIV) relating to the
proposed acquisition by Siris Capital Group, Inc.
Click here to learn more about the investigation http://brodsky-smith.com/839-driv-digital-river-inc.html ,
or call: 877-534-2590.
Genetics, Inc. (Nasdaq: SGEN) today presented data from two ongoing
phase 1 clinical trials evaluating SGN-CD19A, an antibody-drug conjugate
(ADC) in development for the treatment of B-cell malignancies, including
non-Hodgkin lymphoma (NHL) and acute lymphoblastic leukemia (ALL), at
the 56 th American Society of Hematology (ASH) Annual Meeting
and Exposition taking place in San Francisco, CA December 6-9, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.